These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 18714521)

  • 21. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaphylactic reaction to infliximab in two rheumatoid arthritis patients who had previously received infliximab and resumed.
    Sugiura F; Kojima T; Oba M; Tsuchiya H; Ishiguro N
    Mod Rheumatol; 2005; 15(3):201-3. PubMed ID: 17029063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease.
    Mesko B; Poliska S; Váncsa A; Szekanecz Z; Palatka K; Hollo Z; Horvath A; Steiner L; Zahuczky G; Podani J; Nagy AL
    Genome Med; 2013; 5(6):59. PubMed ID: 23809696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab treatment strategy: dose titration based on response in patients with RA.
    Machold KP
    Nat Clin Pract Rheumatol; 2007 Sep; 3(9):494-5. PubMed ID: 17684503
    [No Abstract]   [Full Text] [Related]  

  • 25. Response of fibroblastic rheumatism to infliximab.
    Romiti R; Levy Neto M; Menta Simonsen Nico M
    Dermatol Res Pract; 2009; 2009():715729. PubMed ID: 20585484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The search continues: finding who will and who will not respond to infliximab.
    Parsi MA
    Inflamm Bowel Dis; 2005 Jan; 11(1):75-6. PubMed ID: 15674118
    [No Abstract]   [Full Text] [Related]  

  • 27. To be or not to be: infliximab during pregnancy?
    Aberra FN
    Inflamm Bowel Dis; 2006 Jan; 12(1):76-8. PubMed ID: 16374264
    [No Abstract]   [Full Text] [Related]  

  • 28. Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis.
    van der Laken CJ; Voskuyl AE; Roos JC; Stigter van Walsum M; de Groot ER; Wolbink G; Dijkmans BA; Aarden LA
    Ann Rheum Dis; 2007 Feb; 66(2):253-6. PubMed ID: 16793840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys.
    Rojas JR; Taylor RP; Cunningham MR; Rutkoski TJ; Vennarini J; Jang H; Graham MA; Geboes K; Rousselle SD; Wagner CL
    J Pharmacol Exp Ther; 2005 May; 313(2):578-85. PubMed ID: 15647331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
    Pavelka K; Jarosová K; Suchý D; Senolt L; Chroust K; Dusek L; Vencovský J
    Ann Rheum Dis; 2009 Aug; 68(8):1285-9. PubMed ID: 19351624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients.
    Wijbrandts CA; Remans PH; Klarenbeek PL; Wouters D; van den Bergh Weerman MA; Smeets TJ; Vervoordeldonk MJ; Baeten D; Tak PP
    Arthritis Rheum; 2008 Nov; 58(11):3330-9. PubMed ID: 18975323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
    Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The formation of infliximab and anti-infliximab immune complexes as an explanation for non-responding to infliximab treatment of rheumatoid arthritis: observational study in 4 patients].
    van der Laken CJ; Voskuyl AE; Roos JC; Stigter van Walsum M; de Groot ER; Wolbink GJ; Dijkmans BA; Aarden LA
    Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1672-7. PubMed ID: 18714521
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.